PANTHERO Trademark

Trademark Overview

On Tuesday, December 7, 2010, a trademark application was filed for PANTHERO with the United States Patent and Trademark Office. The USPTO has given the PANTHERO trademark a serial number of 85192386. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 22, 2014. This trademark is owned by Novartis AG. The PANTHERO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, ophthalmology, in tissue and organ transplantation, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; vaccines; diagnostic preparations for medical use
panthero

General Information

Serial Number85192386
Word MarkPANTHERO
Filing DateTuesday, December 7, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, and for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, ophthalmology, in tissue and organ transplantation, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; vaccines; diagnostic preparations for medical use
Pseudo MarkPANT HERO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, December 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 28, 2014EXTENSION 5 GRANTED
Thursday, April 24, 2014EXTENSION 5 FILED
Thursday, April 24, 2014TEAS EXTENSION RECEIVED
Wednesday, November 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2013EXTENSION 4 GRANTED
Thursday, November 7, 2013EXTENSION 4 FILED
Thursday, November 7, 2013TEAS EXTENSION RECEIVED
Friday, May 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2013EXTENSION 3 GRANTED
Wednesday, May 8, 2013EXTENSION 3 FILED
Wednesday, May 8, 2013TEAS EXTENSION RECEIVED
Wednesday, November 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 13, 2012EXTENSION 2 GRANTED
Wednesday, November 7, 2012EXTENSION 2 FILED
Thursday, November 8, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 7, 2012TEAS EXTENSION RECEIVED
Friday, May 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2012EXTENSION 1 GRANTED
Wednesday, May 9, 2012EXTENSION 1 FILED
Wednesday, May 9, 2012TEAS EXTENSION RECEIVED
Tuesday, November 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2011PUBLISHED FOR OPPOSITION
Friday, August 12, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 10, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2011ASSIGNED TO LIE
Friday, July 22, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2011NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2011NON-FINAL ACTION WRITTEN
Tuesday, March 1, 2011ASSIGNED TO EXAMINER
Saturday, December 11, 2010NOTICE OF PSEUDO MARK MAILED
Friday, December 10, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 10, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

panthero preparations system treatment pharmaceutical disorders prevention diseases diabetes bacteria based